RHUMBLINE ADVISERS - ASTERIAS BIOTHERAPEUTICS INC ownership

ASTERIAS BIOTHERAPEUTICS INC's ticker is AST and the CUSIP is 04624N107. A total of 67 filers reported holding ASTERIAS BIOTHERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of ASTERIAS BIOTHERAPEUTICS INC
ValueSharesWeighting
Q1 2018$33,000
-36.5%
23,0930.0%0.00%
Q4 2017$52,000
-34.2%
23,0930.0%0.00%
Q3 2017$79,0000.0%23,093
+3.6%
0.00%
Q2 2017$79,000
+54.9%
22,298
+49.6%
0.00%
Q1 2017$51,000
-21.5%
14,908
+6.1%
0.00%
Q4 2016$65,000
+25.0%
14,050
+14.6%
0.00%
Q3 2016$52,000
+85.7%
12,264
+5.1%
0.00%
Q2 2016$28,000
-34.9%
11,664
+4.2%
0.00%
Q3 2015$43,00011,1990.00%
Other shareholders
ASTERIAS BIOTHERAPEUTICS INC shareholders Q2 2016
NameSharesValueWeighting ↓
BROADWOOD CAPITAL INC 5,292,156$7,674,0001.12%
Northeast Financial Consultants Inc 732,265$1,061,0000.36%
Family Management Corp 10,424$15,0000.01%
AJ WEALTH STRATEGIES, LLC 15,000$22,0000.01%
Poehling Capital Management, INC. 3,302$5,0000.00%
A.R.T. Advisors, LLC 48,692$70,0000.00%
Virtu Financial LLC 34,383$50,0000.00%
Founders Capital Management 3,000$4,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 151,854$220,0000.00%
BEACON INVESTMENT ADVISORY SERVICES, INC. 10,500$15,0000.00%
View complete list of ASTERIAS BIOTHERAPEUTICS INC shareholders